Literature DB >> 9105063

Surface activity of sputum from acute asthmatic patients.

K Kurashima1, M Fujimura, T Matsuda, T Kobayashi.   

Abstract

The cause of airway resistance that develops during an asthma attack is not fully understood. Besides bronchospasm and airway edema, a surfactant dysfunction has been suggested as a reason for an increase in airway resistance. This study sought to determine if surface activity of airway fluid is altered in acute asthmatic attacks. Sputa were collected serially from seven patients with acute asthmatic attacks and compared with that of normal subjects (n = 15) and subjects with stable asthma (n = 14). Sputa were analyzed for minimal surface tension (STmin), phospholipids (PL), and total proteins (TP). There were no significant differences in STmin, PL, and TP between sputa from normal subjects and subjects with stable asthma. In the acute phase of the attack, TP, TP/PL ratio, and STmin significantly increased. However, in the recovery phase of the attack, TP/PL ratio and STmin significantly decreased. These data demonstrated that surface properties of airway fluid deteriorated in the early phase of the asthma attack, but were ameliorated in the recovery phase possibly by the surfactant recruitment. The drastic changes in surface activity of sputum suggest that changes in airway surfactant may be partly involved in the pathogenesis of the airway obstruction during asthmatic attack.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105063     DOI: 10.1164/ajrccm.155.4.9105063

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

Review 1.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

2.  Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.

Authors:  Scott S Wagers; Ryan J Norton; Lisa M Rinaldi; Jason H T Bates; Burton E Sobel; Charles G Irvin
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 3.  Lung surfactant in subacute pulmonary disease.

Authors:  Gehan Devendra; Roger G Spragg
Journal:  Respir Res       Date:  2002-04-04

Review 4.  The role of surfactant in asthma.

Authors:  Jens M Hohlfeld
Journal:  Respir Res       Date:  2001-10-15

5.  Electronic cigarette vapor alters the lateral structure but not tensiometric properties of calf lung surfactant.

Authors:  Rebecca J Przybyla; Jason Wright; Rajan Parthiban; Saeed Nazemidashtarjandi; Savas Kaya; Amir M Farnoud
Journal:  Respir Res       Date:  2017-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.